Literature DB >> 18221627

Rapid onset of true antidepressant action.

Matthew J Taylor1.   

Abstract

Antidepressant medications generally are considered to have a delayed onset of action; however, recent evidence is beginning to challenge this conventional wisdom. Meta-analysis of placebo-controlled, randomized trials reveals that patients with depression are more likely to experience a clinically significant response with antidepressants than with placebo by the end of the first week of treatment. About one third of the total treatment benefit over 6 weeks is evident by the end of the first week. Early response to antidepressants is not necessarily a placebo response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18221627     DOI: 10.1007/s11920-007-0064-0

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  15 in total

1.  [Treatment of depressive states with an iminodibenzyl derivative (G 22355)].

Authors:  R KUHN
Journal:  Schweiz Med Wochenschr       Date:  1957-08-31

2.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

Authors:  Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie M Biggs; G K Balasubramani; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

3.  Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo.

Authors:  J W Stewart; F M Quitkin; P J McGrath; J Amsterdam; M Fava; J Fawcett; F Reimherr; J Rosenbaum; C Beasley; P Roback
Journal:  Arch Gen Psychiatry       Date:  1998-04

4.  Use of pattern analysis to identify true drug response. A replication.

Authors:  F M Quitkin; J D Rabkin; J M Markowitz; J W Stewart; P J McGrath; W Harrison
Journal:  Arch Gen Psychiatry       Date:  1987-03

Review 5.  Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons.

Authors:  M J Campbell; S A Julious; D G Altman
Journal:  BMJ       Date:  1995-10-28

6.  How to assess the onset of antidepressant effect: comparison of global ratings and findings based on depression scales.

Authors:  H J Möller; H Müller; H P Volz
Journal:  Pharmacopsychiatry       Date:  1996-03       Impact factor: 5.788

Review 7.  Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis.

Authors:  Matthew J Taylor; Nick Freemantle; John R Geddes; Zubin Bhagwagar
Journal:  Arch Gen Psychiatry       Date:  2006-11

8.  Identification of true drug response to antidepressants. Use of pattern analysis.

Authors:  F M Quitkin; J G Rabkin; D Ross; J W Stewart
Journal:  Arch Gen Psychiatry       Date:  1984-08

Review 9.  The human cost of not achieving full remission in depression.

Authors:  Roger S McIntyre; Claire O'Donovan
Journal:  Can J Psychiatry       Date:  2004-03       Impact factor: 4.356

10.  Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition.

Authors:  Catherine J Harmer; Nicholas C Shelley; Philip J Cowen; Guy M Goodwin
Journal:  Am J Psychiatry       Date:  2004-07       Impact factor: 18.112

View more
  4 in total

1.  A longitudinal etiologic model for symptoms of anxiety and depression in women.

Authors:  K S Kendler; C O Gardner
Journal:  Psychol Med       Date:  2011-04-11       Impact factor: 7.723

2.  Depression-like deficits in rats improved by subchronic modafinil.

Authors:  Ralf Regenthal; Holger Koch; Christian Köhler; Rainer Preiss; Ute Krügel
Journal:  Psychopharmacology (Berl)       Date:  2009-03-03       Impact factor: 4.530

3.  Influence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treatment-free Russian patients with moderate or severe depression: An explorative psychopharmacological study with naturalistic design.

Authors:  Lisanne M Geers; Taichi Ochi; Natalya M Vyalova; Innokentiy S Losenkov; Diana Z Paderina; Ivan V Pozhidaev; German G Simutkin; Nikolay A Bokhan; Bob Wilffert; Daniël J Touw; Anton J M Loonen; Svetlana A Ivanova
Journal:  Hum Psychopharmacol       Date:  2021-11-17       Impact factor: 2.130

4.  Early changes in emotional processing as a marker of clinical response to SSRI treatment in depression.

Authors:  B R Godlewska; M Browning; R Norbury; P J Cowen; C J Harmer
Journal:  Transl Psychiatry       Date:  2016-11-22       Impact factor: 6.222

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.